T
TOVX
THERIVA BIOLOGICS INC
0.2306
-0.0266-10.34%After Hours: 0.2289 -0.0017 -0.74%19:54 04/10 EDT
OPEN/PREV CLOSE0.2381/0.2572
TODAY RANGE0.2300-0.2512
VOL1.97M
MARKET CAP10.58M
52 WEEK RANGE0.1628-1.500
AVG VOL (3M)12.38M
% TURNOVER4.30%
TURNOVER--
P/E (TTM)-0.1109
% RANGE8.05%
EPS(TTM)-2.0797
P/E(FORWARD)-1.0482
P/B0.5350
BVPS0.4310
DIVIDEND--
P/S--
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP10.41M
SHARES OUTSTANDING45.89M
NEXT EARNINGS05/12-05/18
FREE FLOAT45.14M
LOT SIZE1
EX-DATE08/26/2024
News
Press Releases
Financial Reports
Profile
TipRanks·2d ago
Theriva Biologics Faces Delays in Warrant Approval Meeting
Benzinga·2d ago
12 Health Care Stocks Moving In Thursday's Intraday Session
Dow Jones·03/31 21:07
Theriva Biologics Raised to Buy From Hold by Maxim Group
Dow Jones·03/31 21:07
Theriva Biologics Price Target Announced at $1.00/Share by Maxim Group
Benzinga·03/31 20:57
Maxim Group Upgrades Theriva Biologics to Buy, Announces $1 Price Target
TipRanks·03/31 13:48
Theriva Biologics upgraded to Buy at Maxim on clearer VCN-01 path
TipRanks·03/31 11:54
Theriva Biologics upgraded to Buy from Hold at Maxim
TipRanks·03/23 12:27
Theriva Biologics Advances VCN-01 Into Pivotal Phase 3
TipRanks·03/23 12:10
Theriva Biologics announces outcome of Type B End-of-Phase 2 meeting with FDA
TipRanks·03/13 13:38
Theriva Biologics price target lowered to $4 from $7 at Alliance Global
Seeking Alpha·03/12 19:12
Theriva Biologics GAAP EPS of -$2.08
Benzinga·03/12 12:35
Theriva Biologics Q4 EPS $(0.12) Beats $(0.50) Estimate
TipRanks·03/12 12:07
Theriva Biologics reports FY25 EPS ($2.08) vs. ($19.03) last year
Same Industry
Name/Symbol
Change%
Price